Sangamo Therapeutics, Inc. (SGMO)

0.3938 +0.01 (+3.55%) USD  |  NASDAQ  |  Jan 22, 10:46
More

Sangamo Therapeutics EPS Diluted from Accounting Change (Quarterly)

EPS Diluted from Accounting Change (Quarterly) Chart

View EPS Diluted from Accounting Change (Quarterly) for SGMO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Accounting Change (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Accounting Change (Quarterly) Benchmarks

View EPS Diluted from Accounting Change (Quarterly) Benchmarks
Start Trial
Arcturus Therapeutics Holdings, Inc. --
AIM ImmunoTech, Inc. --
Perspective Therapeutics, Inc. --
Protalix Biotherapeutics, Inc. --
Armata Pharmaceuticals, Inc. --